30
Participants
Start Date
December 12, 2024
Primary Completion Date
May 20, 2025
Study Completion Date
May 31, 2025
Palomacare® vaginal gel is a medical device with CE class IIa.
"The duration of the study for each patient will be approximately 11-12 days and the treatment for groups A and B will be 6 days.~In a first pilot study in asymptomatic women, a tendency towards a positive effect on the composition of vaginal fluid was already observed, as assessed by diagnostic tests and classified using a Likert scale. A subsequent study showed that treatment with a different vaginal gel but with an identical concentration of ingredients from Palomacare® vaginal gel, for 21 consecutive days, is able to improve the composition of vaginal fluid.~Based on these preliminary data, it is possible to hypothesize that the action of Palomacare® vaginal gel will have a positive effect on the composition of vaginal fluid in patients affected by dysbiosis, whether asymptomatic or not."
RECRUITING
Instituto Palacios de Salud y Medicina de la Mujer, Madrid
RECRUITING
Clínica Sagrada Familia, Barcelona
Procare Health Iberia S.L.
INDUSTRY